Showing results (91-100 of 248) with videos related to

Sort By:
Pageof 25
Journal of Nephrology|March 5, 2015
Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too lowJennifer L Ennis, Elaine M Worcester, Fredric L Coe, et al.
Critical Care Medicine|July 13, 2000
Risk assessment and standardized nosocomial infection rate in critically ill childrenN Singh-Naz, B M Sprague, K M Patel, et al.
The Journal of Physical Chemistry. B|July 21, 2006
Breathing mode dynamics and elastic properties of gold nanoparticlesCharles F Vardeman, Patrick F Conforti, Megan M Sprague, et al.
Transplantation|July 17, 2001
Posttransplant bone disease: a case illustrating dramatic improvements in bone density with vitamin D replacement therapyR K Dhingra, S M Sprague, A O Ojo, et al.
American Journal of Nephrology|November 12, 2005
Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferolAnna L Zisman, Walid Ghantous, Pamela Schinleber, et al.
Environmental and Molecular Mutagenesis|January 1, 1987
A recombinagenic effect of strychnine in Salmonella typhimuriumG R Hoffmann, K M Sprague, J A Wrobel, et al.
Experimental Brain Research|January 1, 1992
Longterm impairment of cat optokinetic nystagmus following visual cortical lesionsJ M Flandrin, J H Courjon, G A Orban, et al.
Critical Care Medicine|May 1, 1996
Risk factors for nosocomial infection in critically ill children: a prospective cohort studyN Singh-Naz, B M Sprague, K M Patel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 28, 2014
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKDDaniel W Coyne, Seth Goldberg, Mark Faber, et al.
Kidney International|January 1, 1980
Parathyroid hormone-mediated aluminum deposition and egress in the ratG H Mayor, S M Sprague, M R Hourani, et al.
Pageof 25